Filing Details
- Accession Number:
- 0001209191-19-060767
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-16 19:40:47
- Reporting Period:
- 2019-12-13
- Accepted Time:
- 2019-12-16 19:40:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326110 | Nantkwest Inc. | NK | Biological Products, (No Disgnostic Substances) (2836) | 431979754 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1424620 | C John Thomas | C/O Nantkwest, Inc. 3530 John Hopkins Court San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-12-13 | 10,000 | $2.48 | 350,069 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-12-13 | 10,000 | $2.98 | 340,069 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-12-16 | 10,000 | $3.14 | 330,069 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13,886 | Indirect | See footnote |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person.
- Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.